BioSpace News Archive

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that its prophylactic breast cancer vaccine is making progress towards clinical trials.

Paper supports use of nVNS as a front-line therapy for acute and preventative treatment of cluster headache and as an effective option for the treatment of migraine headache

Ibex Medical Analytics, the pioneer in artificial intelligence (AI)-powered cancer diagnostics, today announced outstanding outcomes in a clinical validation study for the first and only AI-based solution used by pathologists in routine clinical practice.

Sun Genomics, the direct-to-consumer personalized probiotics and gut health company, announced today the launch of Floré Defense: a custom blend of prebiotics, probiotics, and herbal supplements designed for the gut-lung microbiome axis and maintaining the body’s natural immune response to potential respiratory infection.

Innovative Cellular Therapeutics (ICT), a clinical stage biotechnology company developing a comprehensive platform of chimeric antigen receptor (CAR) T cell therapies for solid and liquid tumors, today announced that it will present new clinical data at the LifeSci Partners Private Company Virtual Summer Symposium on August 5, 2020. “We have seen a 71% Overall Response Rate with 14% Complete Response in seven metastatic colon cancer patients

Publication of the Phase 2 U.S. study data show that RHB-102 (Bekinda ® ) 12mg delivers a clinically meaningful improvement in overall stool consistency response versus placebo in patients with diarrhea-predominant irritable bowel syndrome (IBS-D), meeting the study’s primary endpoint -- In addition, the publication highlights that elevated baseline C-reactive protein (CRP) may be used to identify treatment responders in this complex disease, which lacks reliable predictive markers -- T

Therapeutics Solution International, Inc., (OTC Markets: TSOI), reported new data demonstrating that the blueberry derived compound pterostilbene possesses numerous brain protective and potentially brain regenerative activities.

Health Canada has authorized with conditions the drug remdesivir manufactured by Gilead Sciences Canada, Inc. for the treatment of patients with severe symptoms of COVID-19 who have pneumonia and require extra oxygen to help them breathe.

Nashville NeuroCare Therapy, the flagship neuroCare Centers of America clinic in Tennessee, today announced it is celebrating its 10-year anniversary of providing Transcranial Magnetic Stimulation (TMS) Therapy for depression, as the company continues to focus on leveraging innovative technologies and its personalized care approach of providing medication-free treatment options.

Matrix Medical Network has formed a strategic committee of trusted clinical advisors that includes distinguished industry experts whose focus will be to guide the strategy and clinical practices of Matrix’s COVID-19 support programs